Gilead Sciences Statistics and Revenue Totals (2023)
Last Updated on: January 8th, 2023
Here are a few of the most interesting Gilead Sciences statistics I was able to dig up including Gilead Sciences revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Gilead Sciences Facts
- Website: Official Website
- Year Founded: 1987
- Headquarters: Foster City, CA
- Founder(s): Michael Riordan
- Current Chief Executive: John Milligan
- Subsidiaries / Brands: Atripla, Biktarvy, Complera, Descovy, Emtriva, Genvoya, Odefsey, Stribild, Truvada, Tybost, Viread, Epclusa, Harvoni, Hepsera, Sovaldi, Vemlidy, Viread, Vosevi, Yescarta, Zydelig, Letairis, Lexiscan, Ranexa, Cayston, Tamiflu, AmBisome, Macugen, Biktarvy, Remdesivir, Filgotnib, Cilofexor, GLPG-1690, KTE-X19, Axi-cel,
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. (source)
Gilead Sciences Statistics
Gilead Sciences Revenue Totals
Gilead annual revenue:
- 2021: $27.305 billion
- 2020: $24.689 billion
- 2019: $22.449 billion
- 2018: $22.127 billion
- 2017: $26.107 billion
- 2016: $30.390 billion
- 2015: $32.639 billion
- 2014: $24.890 billion
- 2013: $11.202 billion
Gilead annual net income:
- 2021: $6.225 billion
- 2020: $123 million
- 2019: $5.364 billion
- 2018: $5.455 billion
- 2017: $4.644 billion
- 2016: $13.488 billion
- 2015: $18.106 billion
- 2014: $12.059 billion
- 2013: $3.057 billion
Additional Gilead Sciences Statistics
Number of countries Gilead has operations in:
Last updated 9/1/19
Other Topics to Check Out:
Please note that some of these numbers are easier to find than others. A few of these Gilead Sciences statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.
Related Categories:
Related Tags: